Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

September 7, 2023

Primary Completion Date

June 7, 2024

Study Completion Date

June 7, 2024

Conditions
Endometrial CancerSurvivorship
Interventions
OTHER

PREVENT Cardiovascular Health Assessment Tool

Participants will access a heart health information visualization tool online using a personal device or a study tablet computer using their e-mail address to log-in. Investigators will review participant lab results specifically related to their cardiovascular health (e.g. blood pressure, cholesterol) in order to personalize the heart health tool for participants. A brief survey before and after use of the tool will also be completed by participants.

OTHER

Survey

A brief survey before and after use of the tool will also be completed by participants.

OTHER

Interview Regarding Heart Health

Participants will be asked questions related to their heart health.

Trial Locations (1)

27157

Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT05796518 - Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors | Biotech Hunter | Biotech Hunter